Novartis, Sandoz In Tangle With Trade Channels Over Direct Drug Sales In India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A five year-long dispute over drug sales with India's largest trade body - the Pharmaceutical Wholesalers Association - has returned to hound Novartis. The powerful trade association has boycotted all products of Novartis and its generic drugs arm Sandoz in Mumbai, alleging that the two companies have been selling some high-value drugs directly to patients, thereby violating agreements over trade margins and also circumventing laws governing price control of drugs in India